GoldenGolden
Advanced Search
New Leaf Venture Partners

New Leaf Venture Partners

A venture capital firm in New York focused on investments in healthcare technology companies

New Leaf Venture Partners is a venture capital firm in New York focused on investments in healthcare technology companies. Founded 2005 in New York, United States by James Niedel, Jeani Delagardelle, Philippe Chambon, Ronald Hunt, and Vijay Lathi, this venture capital firm invests in debt, early stage ventures, late stage ventures and private equity. Its portfolio companies include Iterum Therapeutics, Aptinyx, Kyruus, AiCure, and Edgewise Therapeutics. As of February 2020, New Leaf Venture Partners has made 155 investments. Their most recent investment was on Nov 7, 2019, when AiCure raised $24.5M. New Leaf Venture Partners has had 39 exits, the most notable of which include Alector, Aptinyx, and Wave Life Sciences. The company has raised four funds, their latest being New Leaf Ventures IV. The company specifically focuses on later stage biopharmaceutical products, early stage medical devices, and laboratory infrastructure technologies.

Timeline

2005
Founded

People

Name
Role
LinkedIn

Christina Kim

Analyst

Dan Becker

Principal

Philippe Chambon

Managing Director and founder

Rebecca Luse

Vice President

Ron Hunt

Managing Director

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

AiCure

BrightInsight

CuraSen Therapeutics

Edgewise Therapeutics

Harpoon Therapeutics

Passage Bio

Qlaris Bio

Renovacor

TigerConnect

News

Title
Author
Date
Publisher
Description
FinSMEs
June 21, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Heather Landi
April 5, 2021
FierceHealthcare
Cleo Health hauled in $40 million to scale up its family benefits platform for working parents and families, BrightInsight banked $101 million to grow its digital health platform for biopharma and medtech companies and more funding news in March.
AlleyWatch
October 10, 2020
AlleyWatch
The Pulse of New York Tech

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.